-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
BioXcel Therapeutics, Inc. quarterly/annual Costs and Expenses history and growth rate from Q1 2017 to Q2 2024.
- BioXcel Therapeutics, Inc. Costs and Expenses for the quarter ending June 30, 2024 was $18.4M, a 65.2% decline year-over-year.
- BioXcel Therapeutics, Inc. Costs and Expenses for the twelve months ending June 30, 2024 was $112M, a 43% decline year-over-year.
- BioXcel Therapeutics, Inc. annual Costs and Expenses for 2023 was $173M, a 8.21% increase from 2022.
- BioXcel Therapeutics, Inc. annual Costs and Expenses for 2022 was $160M, a 49.6% increase from 2021.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)